BlueLinx Announces Second-Quarter Results
August 04, 2016 07:30 ET
|
BlueLinx Corporation
– Debt principal reduction of $63.6 million from Q2 2015 – – Net working capital reduced by $64.5 million from Q2 2015 – ATLANTA, Aug. 04, 2016 (GLOBE NEWSWIRE) -- BlueLinx Holdings Inc....
Progenics Pharmaceuticals Announces Second Quarter 2016 Financial and Business Results
August 04, 2016 07:30 ET
|
Progenics Pharmaceuticals
On July 19, the Company Announced FDA Approval of RELISTOR® Tablets, Triggering a $50 Million Milestone Ultra-Orphan Radiotherapeutic Candidate AZEDRA® Registrational Trial Topline Results...
Stein Mart Announces Second Quarter 2016 Earnings Release and Conference Call
August 04, 2016 07:30 ET
|
Stein Mart, Inc.
JACKSONVILLE, Fla., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Stein Mart, Inc. (NASDAQ:SMRT) will release its second quarter 2016 financial results before the U.S. financial markets open on Friday, August...
Pacira Pharmaceuticals, Inc. Reports Second Quarter 2016 Financial Results
August 04, 2016 07:30 ET
|
Pacira Pharmaceuticals, Inc
-- Total Net Revenues Up 18% Year-Over-Year ---- EXPAREL® Net Product Sales Up 15% Year-Over-Year ---- Conference Call Today at 9 a.m. ET -- PARSIPPANY, N.J., Aug. 04, 2016 (GLOBE NEWSWIRE) --...
Repligen Reports Second Quarter 2016 Financial Results
August 04, 2016 07:30 ET
|
Repligen Corporation
WALTHAM, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for...
MacroGenics to Participate in Two Upcoming Investor Conferences
August 04, 2016 07:30 ET
|
MacroGenics, Inc.
Rockville, MD, Aug. 04, 2016 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
Genocea Reports Second Quarter 2016 Financial Results
August 04, 2016 07:30 ET
|
Genocea Biosciences
CAMBRIDGE, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today...
Minerva Neurosciences Reports Second Quarter 2016 Financial Results and Business Updates
August 04, 2016 07:30 ET
|
Minerva Neurosciences, Inc.
Positive clinical data advance development with MIN-101 in schizophrenia and MIN-117 in major depressive disorder Additional trials also planned with MIN-202 in insomnia disorder and major...
Efore publishes preliminary H1/2016 numbers and lowers its financial estimate for 2016
August 04, 2016 07:30 ET
|
Enedo Oyj
Espoo, Finland, 2016-08-04 13:30 CEST (GLOBE NEWSWIRE) --
EFORE PLC Stock Exchange Release August 4, 2016 14.30 p.m.
Preliminary net sales for...
Valero Energy Partners LP Reports Second Quarter 2016 Results
August 04, 2016 07:27 ET
|
Valero Energy Partners LP
Reported net income attributable to partners of $49 million and EBITDA of $64 million. Reported net cash provided by operating activities of $59 million and distributable cash flow of...